 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
| Barbeau E, Christiani D, Emmons K, Levenstein C, Rosen J, Sorensen G, Spinney R, Youngstrom R. Finding common ground: how public health can work with organized labor to protect workers from environmental tobacco smoke. J Pub Health Policy 1997; 18:453-464. |
| Christiani DC. Smoking and the molecular epidemiology of lung cancer. Clin Chest Med 2000; 21:87-93. |
| Christiani DC and Gong MN. Occupational lung cancer. In: Occupational Disorders of the Lung, DF Hendrick, PS Burge, WS Beckett, A Churg (eds). Saunders: London (in press, 2002). |
| Christiani DC and Monson RR. Occupation. In: Cancer Prevention: The Causes and Prevention of Cancer, Colditz GA and Hunter D (eds). Kluwer Academic Publications 2000; 49-56 |
| Christiani DC, Sharp R, Collman G, Suk W. Applying genomic technologies in environmental health research: challenges and opportunities. J Occup Environ Med 2001; 43:526-533. |
| Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo Zf, Ashok TD, Mark EJ, Wain JC, Christiani DC, Kelsey KT. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21:965-971. |
| Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC. The p53 codon 72 polymorphism and lung-cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9:1037-1042. |
| Garcia-Closas M, Kelsey KT, Wiencke JK, Wain JC, Christiani DC. Glutathione S-transferase class mu polymorphism and lung-cancer susceptibility; interactions with CYP1A1 MspI polymorphism and cigarette dose. Cancer Causes and Control 1997; 8:544-553. |
| Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC. XPD and XRCCI genetic polymorphisms are prognostic factors in advanced non-small cell cancer patients treated with platinum chemotherapy. J Clin Oncol. 2004 Jul 1;22(13):2594-601. Epub 2004 Jun 1. |
| Hirao T, Nelson HH, Ashok TDS, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer Cancer Res 2001; 61:612-5. |
| Huang C, LoCicero J, Wei J, Christiani DC. Molecular heterogeneity of anti-BCL-2 antibody reactive proteins in paried lung and tumors in humans (submitted January, 2002). |
| Huang WZ, Ryan LM, Satten GG, Thurston SW, Kelsey KT, Wiencke JK, CHristiani DC. Likelihood-based model for using multiple markers in environmental health (submitted January, 2002). |
| Kelsey KT, Nelson HH, Zuo ZF, Gunn L, Wain JC, Mark EJ, Christiani DC, Kim DH, Liu M, Wiencke JK. Polymorphisms in carcinogen metabolizing genes and the occurrence of somatic alterations in non-small cell lung cancer (submitted) |
| Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MA, Wang M, Xu XP, Lee BK, Schwartz BS, Wiencke JK. Ethnic variation in the prevalence of a common NAD(P)H:Quinone Oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Brit J Cancer 1997; 76:852-854. |
| Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT. Promoter hypermethylation of DAP-Kinase: Association with advanced stage in non-small cell lung cancer. Oncogene 2001; 20:1765-70 |
| Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 2001 Apr 15;61(8):3419-24. |
| LaMontagne AD and Christiani DC. Prevention of work-related cancers. In: Cancer Causes and Prevention of Cancer, Colditz GA and Hunter D (eds). Kluwer Academic Publications 2000; 281-300. |
| Lee B, Wain JC, Kelsey KT, Wiencke JK, Christiani DC. Association of diet and smoking with lung cancer location. Am J Resp Crit Care Med 1998; 158:182-187. |
| Lee B, Wain JC, Kelsey KT, Wiencke JK, Christiani DC. Smoking, asbestos exposure and tumor location and histology in lung cancer. Am J Resp Crit Care Med 1998; 157:748-755. |
| Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, Lynch TJ, Wain JC, Su L, Christiani DC. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res 2001; 61:8718-8722. |
| Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain, JC, Lynch TJ, Su L, Christiani DC. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer. 2004 Dec 15;101(12):2802-8 |
| Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lunch carcinoma. Cancer Lett. 2004 Oct 8,214(1):69-79. |
| Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Harber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004 May 20;350(21):2129-39. Epub 2004 Apr 29. |
| Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism. Int J Cancer. 2003 May 10; 104(6):758-63 |
| Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, Christiani DC. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res. 2002 May15;62(10):2819-23. |
| Miller DP, Neuberg D, De Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. A positive interaction between GSTP1 polymorphisms and cumulative smoking exposure associated with lung cancer risk: different modeling approaches. (submitted) |
| Miller DP, Neuberg D, De Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology. 2003 Sep;14(5):545-51. |
| Miller DP, Wain JC, Neuberg D, Christiani DC . An association between GSTP1 polymorphisms and early age onset lung carcinoma in women. (submitted) |
| Monson RR and Christiani DC (eds). Occupational and environmental cancer: Harvard-Teikyo Program Special Issue. Cancer Causes and Control 1997; 8(3). |
| Moy EV and Christiani DC. Environmental exposures and cancer. In: Women and Health, M Goldman and M Hatch (eds), Academic Press, San Diego, 2000; 634-648. |
| Nelson H, Christiani DC, Wiencke JK, Wain JC, Mark EJ, Kelsey KT. Implications of k-ras mutation for lung cancer in women and as a prognostic marker for early-stage disease. J Nat Cancer Inst 1999; 91:2032-2038. |
| Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT. K-ras mutation and occupational asbestos exposure in lung adenocarcinoma. Cancer Res 1999; 18:4570-4573. |
| Nelson HH, Hirao T, Aldape K, Devi-Ashok T, Christiani DC, Wain JC, Mark EJ, Wiencke JK, Kelsey KT. Chromosome 3p21 loss and p53 protein dysregulation in non-small cell lung cancer (submitted) |
| Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res. 1998; 58:1804-7. |
| Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 1998; 58(9):1804-1807. |
| Schaeffner ES, Miller DP, Wain JC, Christiani DC. Use of an asbestos exposure score and the presence of pleural and parenchymal abnormalities in lung cancer cases. Int J Occup Environ Health 2001; 7:14-18. |
| Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. No association between p21 codon 31 serine-arginine polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):174-5. No abstract available. |
| Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer. 2003 Jun;40(3)259-66. |
| Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2005 Mar;14(3):567-70. |
| Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, Lynch TJ, Wain JC, Neuberg D, Liu G, Christiani DC. Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res. 2005 Feb 15;11(4):1534-8. |
| Wang LI, Giovannucci EL, Hunter D, Neuberg D, Su L, Christiani DC. Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control. 2004 Dec;15(10):977-85 |
| Wang LI, Miller DP, Sai Y, Liu G, Su L, Wain JC, Lynch TJ, Christiani DC. Manganese superoxide dismutase alanine to valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst 2001; 93:1818-1821. |
| Wang LI, Neuberg D, Christani DC. Asbestos exposure, manganese superoxide dismutase (MnSOD) genotype, and lung cancer risk. J Occup Environ Med. 2004 Jun;46(6):556-64. |
| Wang X, Christiani DC, Mark EJ, Nelson H, Wiencke JK, Gunn L, Wain JC, Kelsey KT. Carcinogen exposure, p53 alteration, and k-ras mutation in synchronous multiple primary lung carcinoma. Cancer 1999; 85:1734-1739. |
| Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark EJ, Christiani DC. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 1999; 91:614-619. |
| Xu LL, Wain JC, Miller DP, Thurston S, Su L, Christiani DC. Association of the NQO1:quinone oxidoreductase polymorphism with lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2001; 10:303-309. |
| Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Counterpoint: the myeloperoxidase -463G--> a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1555-9. |
| Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. The myeloperoxidase -463g-to-A polymorphism does not decrease lung cancer susceptibility in Caucasians. submitted September, 2001 |
| Xu LL, Wain JC, Miller DP, Thurston SW, Su L, Lynch TJ, Christani DC. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer:differential susceptibility based on smoking behavior. Cancer Epidemiol Biomarkers Prev 2001 Apr;10(4):303-9. |
| Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su Li, Christiani DC. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res. 2004 Aug 1;10(15):4939-43. |
| Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002 Mar 1;62(5):1377-81. |
| Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. |
| Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-smoking interaction associations for the ERCC1 polymorphism in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):491-6. |
| Zhou W, Liu G, Thurston S, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking and lung cancer. Cancer Epidemiol Biomarkers Prev 2002; 11:15-21. |
| Zhou W, Xu LL, Thurston SW, Liu G, Miller DP, Wain JC, Lynch TJ, Christiani DC. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev 2001; 10:461-6. |
Harvard School of Public Health
665 Huntington Avenue
Boston, MA 02115
Created and maintained by Lynn NeJaime